ビオフェルミン製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証1部 | 医薬品 | 4517/E00960 | BIOFERMIN PHARMACEUTICAL CO.,LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2019/02/01 | 日証協 | 11,690株 | +25.83% | 3,900株 | +22.6% | 23,496株 | +8.12% | 2,765株 | -34.17% |
| 2019/01/25 | 日証協 | 9,290株 | -4.13% | 3,181株 | 0% | 21,732株 | 0% | 4,200株 | +55.21% |
| 2019/01/18 | 日証協 | 9,690株 | -0.36% | 0株 | -100% | 21,732株 | -1.33% | 2,706株 | -37.1% |
| 2019/01/11 | 日証協 | 9,725株 | -0.1% | 3,180株 | 0% | 22,026株 | +10% | 4,302株 | +9999.99% |
| 2019/01/04 | 日証協 | 9,735株 | -4.89% | 0株 | -100% | 20,024株 | +3.09% | 10株 | -99.27% |
| 2018/12/28 | 日証協 | 10,235株 | +5.14% | 1,900株 | -38.71% | 19,424株 | +7.62% | 1,375株 | -1.79% |
| 2018/12/21 | 日証協 | 9,735株 | +2.1% | 3,100株 | -61.73% | 18,049株 | +1.12% | 1,400株 | -71.43% |
| 2018/12/14 | 日証協 | 9,535株 | +14.53% | 8,100株 | +15.88% | 17,849株 | +22.68% | 4,900株 | +204.35% |
| 2018/12/07 | 日証協 | 8,325株 | +6.73% | 6,990株 | +111.82% | 14,549株 | +4.56% | 1,610株 | +61% |
| 2018/11/30 | 日証協 | 7,800株 | +6.85% | 3,300株 | 0% | 13,914株 | -2.79% | 1,000株 | +50.38% |
| 2018/11/22 | 日証協 | 7,300株 | 0% | 0株 | -100% | 14,314株 | -31.23% | 665株 | -92.93% |
| 2018/11/16 | 日証協 | 7,300株 | -21.4% | 100株 | -96.67% | 20,814株 | +43.41% | 9,400株 | +213.23% |
| 2018/11/09 | 日証協 | 9,288株 | +1.76% | 3,000株 | +13.04% | 14,514株 | -27.84% | 3,001株 | -67.38% |
| 2018/11/02 | 日証協 | 9,127株 | -17.03% | 2,654株 | -33.65% | 20,113株 | +62.54% | 9,200株 | +736.36% |
| 2018/10/26 | 日証協 | 11,000株 | +35.8% | 4,000株 | +238.98% | 12,374株 | +10.35% | 1,100株 | -26.67% |
| 2018/10/19 | 日証協 | 8,100株 | -10.99% | 1,180株 | +1080% | 11,213株 | +0.81% | 1,500株 | +36.36% |
| 2018/10/12 | 日証協 | 9,100株 | -35.92% | 100株 | -99.41% | 11,123株 | -29.7% | 1,100株 | -82.84% |
| 2018/10/05 | 日証協 | 14,200株 | +51.06% | 16,900株 | -22.12% | 15,823株 | +95.08% | 6,410株 | +482.73% |
| 2018/09/28 | 日証協 | 9,400株 | +16.05% | 21,700株 | +294.55% | 8,111株 | -38.17% | 1,100株 | +37.5% |
※株式分割は考慮していませんのでご注意ください。